Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma

被引:56
|
作者
Roh, MS
Lee, JI
Choi, PJ
机构
[1] Dong A Univ Coll Med, Dept Pathol, Pusan 602713, South Korea
[2] Dong A Univ Coll Med, Dept Thorac & Cardiovasc Surg, Pusan, South Korea
[3] Dong A Univ Coll Med, Med Res Ctr Canc Mol Therapy, Pusan, South Korea
来源
DISEASES OF THE ESOPHAGUS | 2004年 / 17卷 / 04期
关键词
esophageal squamous cell carcinoma; prognosis; survival; tumor budding;
D O I
10.1111/j.1442-2050.2004.00436.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
We examined the prognostic significance of tumor budding in patients with esophageal squamous cell carcinoma, particularly in comparison to other routine pathological findings. Fifty-six cases who underwent an esophagectomy were reviewed. We defined tumor budding as an isolated single cancer cell or a cluster composed of fewer than five cancer cells and divided these into two grades; low-grade (< 5 budding foci) and high-grade (greater than or equal to 5 budding foci) within a microscopic field of x200. There were 22 (39.3%) and 34 (60.7%) cases with low- and high-grade budding, respectively. There were significant differences in the patients with low- and high-grade budding in relation to tumor size, pT stage, lymphovascular invasion, perineural invasion, circumferential resection margin involvement, and AJCC stage (P < 0.05). The 3-year survival rates of the patients with low- and high-grade budding were 72.3% and 30.7%, respectively (P = 0.04). We propose that tumor budding may be a pathological marker suggesting high malignancy potential and decreased postoperative survival in patients with esophageal squamous cell carcinoma.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 50 条
  • [21] Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma
    Shibata, Takahiro
    Matsuo, Yoichi
    Shamoto, Tomoya
    Hirokawa, Takahisa
    Tsuboi, Ken
    Takahashi, Hiroki
    Ishiguro, Hideyuki
    Kimura, Masahiro
    Takeyama, Hiromitsu
    Inagaki, Hiroshi
    ONCOLOGY REPORTS, 2013, 29 (06) : 2127 - 2132
  • [22] Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma
    Matsumoto, Yasunori
    Kano, Masayuki
    Akutsu, Yasunori
    Hanari, Naoyuki
    Hoshino, Isamu
    Murakami, Kentaro
    Usui, Akihiro
    Suito, Hiroshi
    Takahashi, Masahiko
    Otsuka, Ryota
    Xin, Hu
    Komatsu, Aki
    Iida, Keiko
    Matsubara, Hisahiro
    ONCOLOGY REPORTS, 2016, 36 (05) : 2535 - 2543
  • [23] Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma
    Qin, Guohui
    Lian, Jingyao
    Yue, Dongli
    Chen, Xinfeng
    Nan, Shufeng
    Qi, Yu
    Li, Bing
    Cui, Guanghui
    Li, Xiangnan
    Zhao, Song
    Zhang, Yi
    ONCOLOGY REPORTS, 2017, 38 (03) : 1724 - 1732
  • [24] HES1 as an Independent Prognostic Marker in Esophageal Squamous Cell Carcinoma
    Taleb S.
    Abbaszadegan M.R.
    Moghbeli M.
    Roudbari N.H.
    Forghanifard M.M.
    Journal of Gastrointestinal Cancer, 2014, 45 (4) : 466 - 471
  • [25] The prognostic significance of tumor laterality in patients with esophageal squamous cell carcinoma
    Mine, Shinji
    Yamada, Kazuhiko
    Grabsch, Heike
    Sano, Takeshi
    Ishiyama, Akiyoshi
    Hirasawa, Toshiaki
    Yamamoto, Noriko
    Hiki, Naoki
    Yamaguchi, Toshiharu
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (01) : 66 - 70
  • [26] Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma
    Rosato, Antonio
    Pivetta, Michela
    Parenti, Anna
    Iaderosa, Gaetano A.
    Zoso, Alessia
    Milan, Gabriella
    Mandruzzato, Susanna
    Del Bianco, Paola
    Ruol, Alberto
    Zaninotto, Giovanni
    Zanovello, Paola
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (07) : 1717 - 1722
  • [27] Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma
    Shimada, H
    Nabeya, Y
    Tagawa, M
    Okazumi, S
    Matsubara, H
    Kadomatsu, K
    Muramatsu, T
    Ikematsu, S
    Sakuma, S
    Ochiai, T
    CANCER SCIENCE, 2003, 94 (07) : 628 - 632
  • [28] Tumor budding as a prognostic marker in stage III colorectal carcinoma
    Choi, H. J.
    Park, K. J.
    Shin, J. S.
    Roh, M. S.
    Kwon, H. C.
    Lee, H. S.
    ISUCRS: PROCEEDINGS OF THE XXI BIENNIAL CONGRESS OF THE INTERNATIONAL SOCIETY OF UNIVERSITY COLON AND RECTAL SURGEONS, 2006, : 61 - +
  • [29] Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung
    Taira, Tetsuhiko
    Ishii, Genichiro
    Nagai, Kanji
    Yoh, Kiyotaka
    Takahashi, Yusuke
    Matsumura, Yuki
    Kojima, Motohiro
    Ohmatsu, Hironobu
    Goto, Koichi
    Niho, Seiji
    Takashima, Hiroshi
    Inoue, Hiromasa
    Ohe, Yuichiro
    Ochiai, Atsushi
    LUNG CANCER, 2012, 76 (03) : 423 - 430
  • [30] Tumor Budding and E-Cadherin Expression Are Useful Predictors of Nodal Involvement in T1 Esophageal Squamous Cell Carcinoma
    Nakagawa, Yasuo
    Ohira, Masaichi
    Kubo, Naoshi
    Yamashita, Yoshito
    Sakurai, Katsunobu
    Toyokawa, Takahiro
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Shibutani, Masatsune
    Yamazoe, Sadaaki
    Kimura, Kenjiro
    Nagahara, Hisashi
    Amano, Ryosuke
    Ohtani, Hiroshi
    Yashiro, Masakazu
    Maeda, Kiyoshi
    Hirakawa, Kosei
    ANTICANCER RESEARCH, 2013, 33 (11) : 5023 - 5029